valproic acid has been researched along with osteoprotegerin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Elshamy, KA; Elwakkad, AS; Sibaii, H | 1 |
| Bauer, S; Hallmeyer-Elgner, S; Hofbauer, LC; Kellinghaus, C; Oertel, WH; Rauner, M; Rosenow, F; Strzelczyk, A | 1 |
| Challa, A; Cholevas, V; Nakou, I; Papassava, M; Siomou, E; Tzoufi, M | 1 |
3 other study(ies) available for valproic acid and osteoprotegerin
| Article | Year |
|---|---|
Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
Topics: Alkaline Phosphatase; Animals; Anticonvulsants; Atropine; Biomarkers; Bone Resorption; Disease Models, Animal; Epilepsy; Fish Oils; Male; Osteocalcin; Osteogenesis; Osteoporosis; Osteoprotegerin; Pilocarpine; Propolis; RANK Ligand; Rats; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha; Valproic Acid | 2008 |
Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study.
Topics: Adult; Anticonvulsants; Bone and Bones; Calcium; Carbamazepine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Osteocalcin; Osteoprotegerin; Oxcarbazepine; Phosphates; Prospective Studies; Receptor Activator of Nuclear Factor-kappa B; Valproic Acid | 2013 |
Vitamin D supplementation and bone markers in ambulatory children on long-term valproic acid therapy. A prospective interventional study.
Topics: Adolescent; Alkaline Phosphatase; Anticonvulsants; Biomarkers; Bone and Bones; Bone Remodeling; Child; Dietary Supplements; Epilepsy; Female; Humans; Hydroxycholecalciferols; Male; NF-kappa B; Osteoprotegerin; Prospective Studies; Valproic Acid; Vitamin D; Vitamin D Deficiency; Vitamins | 2019 |